We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Advanced Melanoma

Journal Scan / Research · June 04, 2020

Longitudinal Monitoring of ctDNA in Patients With Melanoma and Brain Metastases Treated With Immune Checkpoint Inhibitors

Clinical Cancer Research

 

Additional Info

Clinical Cancer Research
Longitudinal Monitoring of ctDNA in Patients With Melanoma and Brain Metastases Treated With Immune Checkpoint Inhibitors
Clin. Cancer Res 2020 Apr 22;[EPub Ahead of Print], JH Lee, AM Menzies, MS Carlino, AC McEvoy, S Sandhu, AM Weppler, RJ Diefenbach, SJ Dawson, RF Kefford, MJ Millward, Z Al-Ogaili, T Tra, ES Gray, SQ Wong, RA Scolyer, GV Long, H Rizos

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading